Associate Sponsor

PluriCell Biotech is a pre-clinical stage company creating regenerative medicines based on induced pluripotent stem cells focused on cardiovascular applications. By using robust scalable and cost-effective protocol to generate human heart cells in the lab, PluriCell is conducting animal tests to assess regenerative potential and efficacy data of these high quality and high purity cells. There are currently many unmet medical needs in the cardiology space that could potentially benefit the development of such cost-effective therapies and PluriCell is aiming to address chronic conditions derived from ischemic heart disease, such as heart failure. 

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.